Progressive fibrosing interstitial lung disease: we know it behaves badly, but what does that mean?

Amornpun Wongkarnjana, Christopher J. Ryerson

Source: Eur Respir J, 55 (6) 2000894; 10.1183/13993003.00894-2020
Journal Issue: June
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Amornpun Wongkarnjana, Christopher J. Ryerson. Progressive fibrosing interstitial lung disease: we know it behaves badly, but what does that mean?. Eur Respir J, 55 (6) 2000894; 10.1183/13993003.00894-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interstitial lung disease in systemic sclerosis: where do we stand?
Source: Eur Respir Rev 2015; 24: 411-419
Year: 2015



What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015


Interstitial lung disease; where do we stand without histopathology?
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

Cystic interstitial lung disease - a rare disease?
Source: International Congress 2015 – CC4 Diagnosis of cystic interstitial lung disease
Year: 2015

From life threatening to chronic connective tissue disease-associated interstitial lung disease: all you need to know
Source: Virtual Congress 2020 – From life threatening to chronic connective tissue disease-associated interstitial lung disease (CTD-ILD): all you need to know
Year: 2020

Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019
Year: 2019



Interstitial lung disease: ?course report
Source: Breathe, 16 (3) 200075; 10.1183/20734735.0075-2020
Year: 2020



Idiopathic interstitial pneumonia or idiopathic interstitial pneumonitis: what's in a name?
Source: Eur Respir J, 53 (2) 1800994; 10.1183/13993003.00994-2018
Year: 2019



Idiopathic interstitial pneumonia or idiopathic interstitial pneumonitis: what's in a name?
Source: Eur Respir J, 53 (2) 1801939; 10.1183/13993003.01939-2018
Year: 2019



Does emphysema coexistence with IPF change prognosis?
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015

Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders?
Source: Eur Respir J 2011; 38: 384-391
Year: 2011



What’s new in interstitial lung diseases in children?
Source: Virtual Congress 2021 – Paediatric year in review
Year: 2021


Reply to comment on “The natural history of progressive fibrosing interstitial lung diseases”
Source: Eur Respir J, 56 (6) 2003967; 10.1183/13993003.03967-2020
Year: 2020



Genetics of fibrosing lung diseases
Source: Eur Respir J 2005; 25: 915-927
Year: 2005



Monitoring early lung disease in cystic fibrosis: where are we now?
Source: Breathe 2014; 10: 34-47
Year: 2014



Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up?
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Real-life experience with pirfenidon in idiopathic pulmonary fibrosis: Does early treatment start predict better therapy adherence?
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015


A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016